UNIVERSAL-PEACE-FED
10.9.2020 11:43:11 CEST | Business Wire | Press release
In an attempt to spread hope and optimism during the coronavirus pandemic which has infected more than 27 million people and killed over 189,000 globally, UPF, an NGO in general consultative status with the Economic and Social Council of the United Nations will convene its first virtual International Leadership Conference (ILC) on Sept. 11-13, 2020.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200910005456/en/
The ILC will host concurrent webinars in three, time-zone friendly clusters: the Americas, Asia Pacific, and the combined continents of Europe, Africa, and the Middle East.
“This year has seen dramatic disruptions, not only due to the COVID-19 pandemic but in geopolitics, the world economy, the media, religion and all levels of society,” said Universal Peace Federation Chairman Dr. Thomas G. Walsh.
“When the world’s leaders and citizens gather and listen to each other,” he added, “it’s easy to envision how our friendships can grow, and how we can live as one global family.”
Former Secretary-General of the United Nations, Mr. Ban Ki-moon said at the recent virtual summit “Rally of Hope”, Aug. 9, 2020, he believed that “UPF will become a cornerstone to build lasting peace around the world.”
In addition to addressing major issues of the day, the conference will commemorate the 15-year anniversary of the Universal Peace Federation and the centenary of UPF’s Co-Founder, Rev. Dr. Sun Myung Moon (1920-2012).
Featured speakers in the Europe, Africa and Middle-East Peace-Dialogue will include former heads of state such as Goodluck Jonathan from Nigeria or H.E Marie-Louise Coleiro Preca from Malta, or Dr. Werner Fasslabend, former minister of defense, Austria, religious leaders with a large following such as Prophet Radebe from South Africa or Cheikh Soufi Bilal Diallo from Mali, and business leaders such as the philanthropist Joseph Busha from Zimbabwe.
The September 11-13 program will highlight the work of UPF’s seven Associations: International Summit Council for Peace (ISCP), International Association of Parliamentarians for Peace (IAPP), Interreligious Association for Peace and Development (IAPD), International Media Association for Peace (IMAP), International Association of Academicians for Peace (IAAP), International Association for Peace and Economic Development (IAED) and International Association of First Ladies for Peace (IAFLP).
Please register for the ILC sessions here: http://www.ilc-2020.org . You will then receive by email an invitation including all the links for each session as well as a brief description of each session. In addition to English, translations will be available in Arabic, French, Portuguese, Spanish and Russian. Attendance is free.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200910005456/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press release
New platform brings real-time electrical control to coiled tubing intervention, enabling greater precision, visibility and efficiency across intervention operations SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased p
Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press release
By transforming authoritative legal content into structured legal intelligence, Wolters Kluwer gives AI the context and relationships needed to deliver deeper research and higher-quality results Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI c
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press release
Discovered by Takeda in Japan, ORZEYFUL has the Potential to Redefine Care Beyond Individual Symptom Management for Adults Living with Narcolepsy Type 1 (NT1) Landmark Phase 3 Studies Demonstrated Significant and Meaningful Improvements Across the Full Range of NT1 Symptoms Evaluated in Clinical Trials Compared to Placebo Milestone Marks Third Major Regulatory Approval Secured for ORZEYFUL Around the World Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom